Publications

5808 Results

Burden of metastatic hormone sensitive prostate cancer identifies men more likely to benefit from early docetaxel

Authors
G Gravis;JM Boher;Y Chen;G Liu;K Fizazi;M Carducci;S Oudard;R Dipaola;F Joly;D Jarrard;M Soulie;M Eisenberger;M Habibian;R Dreicer;N Vogelzang;M Hussain;M Kohli;J Garcia;J Picus;C Sweeney
Journal / Conference
Journal of Clinical Oncology 35, 2017 (suppl 6S; abstract 136); ASCO GU Cancers Symposium (February16-18, 2017, Orlando, FL), poster
Year
2017
Research Committee(s)
Genitourinary

Lower PSA at 7 months is prognostic for improved overall survival (OS) in metastatic hormone sensitive prostate cancer (mHSPC) treated with ADT with and without docetaxel (D)

Authors
LC Harshman;Y-H Chen;G Liu;M Carducci;D Jarrard;M Eisenberger;Y-N Wong;N Hahn;M Kohli;M Conney;R Dreicer;N Vogelzang;J Picus;D Shevrin;M Hussain;J Garcia;R DiPaola;C Sweeney
Journal / Conference
Journal of Clinical Oncology 35, 2017 (suppl 6S; abstract 137); ASCO GU Cancers Symposium (February16-18, 2017, Orlando, FL), poster
Year
2017
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/E3805

Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE)

Authors
R Kryscio;EL Abner;A Caban-Holt;M Lovell;P Goodman;J Hartline;A Darke;M Yee;J Crowley;FA Schmitt
Journal / Conference
JAMA Neurology May 1;74(5):567-573
Year
2017
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID28319243
PMC
PMC5506489
Study Number(s)
S0000A

Increasing the availability of statistical tools through mobile development

Authors
C Cook;T Phillips;M Leblanc
Journal / Conference
Society for Clinical Trials Annual Meeting (May 7-10, 2017, Liverpool, UK), poster
Year
2017
Research Committee(s)
Cancer Care Delivery

A phase III blinded study of immediate post-TURBT instillation of gemcitabine versus saline in patients with newly diagnosed or occasionally recurring grade I/II non-muscle invasive cancer: SWOG S0337 (http://www.jurology.com/article/S0022-5347(17)39232-7/fulltext)

Authors
E Messing;C Tangen;D Sahasrabudhe;T Koppie;DP Wood;PC Mack;R Svatek;CP Evans;K Hafez;D Culkin;T Brand;LI Karsh;J Holzbeierlein;S Wilson;G Wu;M Plets;SP Lerner;N Vogelzang;I Thompson
Journal / Conference
Journal of Urology Vol. 197, No. 4S, Supplement, PNFLBA-10; AUA Annual Meeting (May 12-16, 2017, Boston, MA), oral presentation
Year
2017
Research Committee(s)
Genitourinary
Study Number(s)
S0337

Long-chain omega-3 fatty acid and fish intake after colon cancer diagnosis and disease-free, recurrence-free, and overall survival in CALGB 89803 (Alliance)

Authors
EL Van Blarigan;C Fuchs;D Niedzwiecki;X Ye;S Zhang;M Song;L Saltz;R Mayer;RB Mowat;R Whittom;A Hantel;A Benson;D Atienza;M Messino;M Kindler;A Venook;S Ogino;W Willett;EL Giovannucci;JA Meyerhardt
Journal / Conference
Journal of Clinical Oncology 35, 2017 (suppl 4S; abstract 585); ASCO GI Cancers Symposium (January 19-21, 2017, San Francisco, CA), poster
Year
2017
Research Committee(s)
Gastrointestinal
Study Number(s)
C89803

Pre-diagnostic physical activity and outcomes in patients with stage III colon cancer: A correlative analysis of phase III trial NCCTG N0147 (Alliance)

Authors
A Phipps;Q Shi;E Chan;S Gill;RM Goldberg;S Hardikar;PJ Limburg;PA Newcomb;A Shields;F Sinicrope;TJ Zemla;DJ Sargent;SR Alberts
Journal / Conference
American Society of Preventive Oncology Annual Meeting (March 11-14, 2017, Seattle, Washington), poster
Year
2017
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/N0147

Impact of homologous recombination deficiency (HRD) biomarkers on outcomes in triple negative breast cancer (TNBC) patients treated with AC chemotherapy (SWOG S9313)

Authors
P Sharma;W Barlow;A Godwin;H Pathak;K Isakova;AR Hartman;R Wenstrup;H Linden;D Tripathy;G Hortobagyi;D Hayes
Journal / Conference
Proceedings of the American AACR Association for Cancer Research April 2017 Vol 58, abst. 1776 p. 456; AACR Annual Meeting (April 1-5, 2017, Washington, DC), poster
Year
2017
Research Committee(s)
Breast
Study Number(s)
SWOG-9313

A phase II trial of dasatinib in patients with unresectable locally advanced or stage IV mucosal, acral and vulvovaginal melanoma: a trial of the ECOG-ACRIN Cancer Research Group (E2607)

Authors
K Kalinsky;S Lee;K Rubin;DP Lawrence;AJ Iafrarte;DR Borger;K Margolin;M Leitao;A Tarhini;H Koon;A Pecora;A Jaslowski;GI Cohen;TM Kuzel;C Lao;JM Kirkwood
Journal / Conference
Cancer Jul 15;123(14):2688-2697; 2017 Mar 23 [Epub ahead of print]
Year
2017
Research Committee(s)
Melanoma
PMID
PMID28334439
PMC
PMC5498223
Study Number(s)
CTSU/E2607

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

Authors
A Venook;D Niedzwiecki;H-J Lenz;F Innocenti;B Fruth;JA Meyerhardt;D Schrag;C Greene;BH O'Neil;JE Shaw;JN Atkins;AB El-Khoueiry;S Berry;B Polite;EM O'Reilly;R Goldberg;H Hochster;R Schilsky;M Bertagnolli;RJ Mayer;CD Blanke
Journal / Conference
Journal of the American Medical Association Jun 20;317(23):2392-2401
Year
2017
Research Committee(s)
Gastrointestinal
PMID
PMID28632865
PMC
PMC5545896
Study Number(s)
CTSU/C80405